These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37820623)

  • 1. Human vascularized bile duct-on-a chip: a multi-cellular micro-physiological system for studying cholestatic liver disease.
    Du Y; de Jong IEM; Gupta K; Waisbourd-Zinman O; Har-Zahav A; Soroka CJ; Boyer JL; Llewellyn J; Liu C; Naji A; Polacheck WJ; Wells RG
    Biofabrication; 2023 Oct; 16(1):. PubMed ID: 37820623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bile Duct-on-a-Chip With Organ-Level Functions.
    Du Y; Khandekar G; Llewellyn J; Polacheck W; Chen CS; Wells RG
    Hepatology; 2020 Apr; 71(4):1350-1363. PubMed ID: 31465556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
    Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
    J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.
    Stein S; Henze L; Poch T; Carambia A; Krech T; Preti M; Schuran FA; Reich M; Keitel V; Fiorotto R; Strazzabosco M; Fischer L; Li J; Müller LM; Wagner J; Gagliani N; Herkel J; Schwinge D; Schramm C
    J Hepatol; 2021 Apr; 74(4):919-930. PubMed ID: 33197512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
    Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
    Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
    Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
    Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
    Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.
    Washington K; Clavien PA; Killenberg P
    Hum Pathol; 1997 Jul; 28(7):791-5. PubMed ID: 9224746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.
    Soroka CJ; Assis DN; Alrabadi LS; Roberts S; Cusack L; Jaffe AB; Boyer JL
    Hepatology; 2019 Sep; 70(3):871-882. PubMed ID: 30561836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.
    Katt J; Schwinge D; Schoknecht T; Quaas A; Sobottka I; Burandt E; Becker C; Neurath MF; Lohse AW; Herkel J; Schramm C
    Hepatology; 2013 Sep; 58(3):1084-93. PubMed ID: 23564624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
    Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
    Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile Duct-on-a-Chip.
    Du Y; Polacheck WJ; Wells RG
    Methods Mol Biol; 2022; 2373():57-68. PubMed ID: 34520006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.
    Soroka CJ; Assis DN; Boyer JL
    Methods Mol Biol; 2019; 1981():363-372. PubMed ID: 31016667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients.
    Frank AK; Chung BK; De Novales MLL; Engesæter LK; Hoyle HW; Øgaard J; Heslop J; Karlsen TH; Tysoe O; Brevini T; Tchorz JS; Vallier L; Mohorianu I; Sampaziotis F; Melum E
    Dig Dis Sci; 2024 Aug; ():. PubMed ID: 39160386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.
    Tabibian JH; Trussoni CE; O'Hara SP; Splinter PL; Heimbach JK; LaRusso NF
    Lab Invest; 2014 Oct; 94(10):1126-33. PubMed ID: 25046437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
    Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia.
    Chusilp S; Lee C; Li B; Lee D; Yamoto M; Ganji N; Vejchapipat P; Pierro A
    Pediatr Surg Int; 2020 Dec; 36(12):1471-1479. PubMed ID: 33084932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.
    Loarca L; De Assuncao TM; Jalan-Sakrikar N; Bronk S; Krishnan A; Huang B; Morton L; Trussoni C; Bonilla LM; Krueger E; O'Hara S; Splinter P; Shi G; Pisarello MJL; Gores GJ; Huebert RC; LaRusso NF
    Lab Invest; 2017 Nov; 97(11):1385-1396. PubMed ID: 28892096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.